- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01851876
Endometrial Injury and Single Embryo Transfer
May 11, 2013 updated by: Suleyman Guven, Karadeniz Technical University
Endometrial Injury May Increase the Clinical Pregnancy Rate in Normoresponders Underwent Long Agonist Protocol Intracytoplasmic Sperm Injection Cycles With Single Embryo Transfer
Endometrial injury increases clinical pregnancy rate in normoresponder patients undergoing long agonist protocol intracytoplasmic sperm injection cycles with single embryo transfer.
Study Overview
Detailed Description
Endometrial injury means endometrial biopsy on day 3 of menstrual cycle following down regulation in an IVF patient.
Study Type
Interventional
Enrollment (Actual)
118
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- woman age under 35 years
- history of primary infertility
- normoresponder (antral follicle count 5-10 in one ovary in early follicular phase
- having grade I or II embryos for transfer
- agree to undergo endometrial biopsy during the COH cycle. All patients were stimulated with luteal phase long protocol.
Exclusion Criteria:
- endocrinopathies (including diabetes mellitus, hyperprolactinemia, Cushing's disease, and congenital adrenal hyperplasia), any systemic disease, collagen disorder, hypercholesterolemia, sickle cell anemia, and a history of neoplasm; -high risk for or history of OHSS
- using any concurrent medication (e.g., insulin-sensitizing drugs, and GnRH antagonists)
- patients who did not proceed to follicle retrieval
- severe male infertility requiring TESA/TESA
- mullerian tract anomalies
- a history of endometrial instrumentation or surgery within a month of the study
- not agree to undergo endometrial biopsy during the COH cycle.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Endometrial injury
The patients in this group will be subjected to endometrial injury procedure in preceding IVF cycle.
|
Endometrial injury with Endometrial Suction Curette (pipelle) will be performed.
|
|
No Intervention: No endometrial injury
The patients in this group will not be subjected to endometrial injury procedure in presiding IVF cycle.
The patients will be stimulated with standard IVF protocol.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Clinical Pregnancy Rate
Time Frame: up to 6 months
|
up to 6 months
|
|
Clinical Pregnancy Rate
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Suleyman Guven, Karadeniz Technical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
April 1, 2011
Study Completion (Actual)
April 1, 2011
Study Registration Dates
First Submitted
April 26, 2013
First Submitted That Met QC Criteria
May 8, 2013
First Posted (Estimate)
May 13, 2013
Study Record Updates
Last Update Posted (Estimate)
July 1, 2013
Last Update Submitted That Met QC Criteria
May 11, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011/20
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Infertility
-
IVI BilbaoUniversity of the Basque Country (UPV/EHU)WithdrawnPrimary InfertilitySpain
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Amro M. Hetta, M.Sc.Mansoura University; Al-Azhar UniversityNot yet recruiting
-
Ovation FertilityFuture FertilityRecruiting
-
Ain Shams Maternity HospitalUnknownInfertility | Pregnancy | Ovarian Hyperstimulation | Primary Infertility Unspecified
-
Galaxy Pharma (Pvt) LimitedOva IVF & Reproductive Health Clinics, KarachiRecruitingSecondary Infertility | Primary Infertility | Low Responders | Mild to Moderate Male Factor InfertilityPakistan
-
The Cleveland ClinicActive, not recruitingPrimary Uterine InfertilityUnited States
-
Sahlgrenska University Hospital, SwedenThe Swedish Research CouncilCompleted
-
West Coast Fertility CentersUnknownGenital Diseases, Female | Secondary Infertility | Genital Diseases, Male | Primary InfertilityUnited States
Clinical Trials on Endometrial injury
-
University of AarhusUnknown
-
The First Affiliated Hospital of Zhengzhou UniversityUnknown
-
University of Sao PauloTerminated
-
Mansoura UniversityUnknown
-
University of Sao PauloConselho Nacional de Desenvolvimento Científico e TecnológicoTerminated
-
Mansoura UniversityUnknownInfertility | Polycystic Ovarian SyndromeEgypt
-
McGill UniversityUnknown
-
Ain Shams Maternity HospitalUnknown
-
National and Kapodistrian University of AthensCompletedHysteroscopy | Endometrial Injury | Repeated Implantation FailuresGreece
-
Mansoura Integrated Fertility CenterCompletedUnexplained Infertility